Duke University Medical Center
Durham, North Carolina, 27710, United States
NCT Number: NCT04368234
The purpose of this data repository is to provide a secure and centralized storage location and resource for the collection of essential data and medical specimens, across COVID-19 related protocols at Duke.
This study is active but is not currently recruiting participants.
Notify MeAll sexes
Observational
Durham, North Carolina, 27710, United States
The aim of this data repository is to provide a secure and centralized storage location and resource for the collection of core variables of interest, as well as the retaining of relevant patient samples, across COVID-19 related protocols at Duke. The core data variables were in-part selected to specifically match those agreed upon by Academic Medical Centers across the U.S., with the intention of aiding the efficiency and effectiveness of de-identified data reuse for population-level research. An additional benefit is that centralized, shared data storage of demographic and longitudinal variables will reduce subject burden, as many questions will now only need to be asked once, rather than each time a given subject joins another COVID-19 related study at Duke.
This shared data and bio-repository project will house all the core data for all patients with COVID-19 (or suspected cases), as well as individual participants ICFs for all other participating COVID-19 studies enrolling Duke patients. Each participating study will have its own separate IRB approved protocol. Samples may be either collected specifically by the protocol, or include left-over clinical samples from the testing and treatment of patients with COVID-19 at Duke.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Subjects will be included in this data repository if they meet the enrollment criteria of any linked/participating IRB-approved protocol, or if they are not enrolled in another COVID-related study but meet one of the following inclusion criteria:
Studies will include:
Time frame: Up to 5 years
This shared data and bio-repository project will house all the core data for all patients with COVID-19 (or suspected cases), as well as individual participant's Informed Consent Forms for all other participating COVID-19 studies enrolling Duke patients. Each participating study will have its own separate IRB approved protocol. Samples may be either collected specifically by the protocol, or include left-over clinical samples from the testing and treatment of patients with COVID-19 at Duke.
Duke University
Other
Duke Shared Data and Specimen Repository Regarding COVID-19 Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05078905
COVID-19, Coronaviridae Infections
Bethesda, Maryland, United States
View Trial DetailsNCT07215520
COVID-19, Coronaviridae Infections
Colorado Springs, Colorado, United States
View Trial DetailsNCT07709637
COVID-19, COVID-19 (SARS-CoV-2 Infection)
Seoul, South Korea
View Trial DetailsNCT05877534
Autonomic Nervous System Diseases, COVID-19
Stockholm, Sweden
View Trial Details